2023-03-23
This Guardian article from June 2021 may or may not have relevance to the behaviour of our MPs in Parliament at Andrew Bridgen's recent Friday 17th debate on the safety and efficacy of the Covid booster shots.
“In the context of health-related APPGs, payments from the pharmaceutical industry represent institutional conflicts of interest as they create circumstances where the primary interest, policymaking in the interests of public health, is at risk of being unduly influenced by the secondary interest, the pharmaceutical industry’s goal of maximising profits”
Either way, it does highlight the potential for conflicts of interest which some suspect pervade every nook and cranny of "our" governmental and medical regulatory and health delivery complex.
